“Healthcare navigation network visualization — white paper banner”

The Fragmented Patient Journey: Why Healthcare Navigation Is the Missing Link in UK Digital Health

An analytical review of systemic gaps, digital health opportunities, and the case for integrated patient navigation

WHITE PAPER

The Fragmented Patient Journey: Why Healthcare Navigation Is the Missing Link in UK Digital Health

An Analytical Review of Systemic Gaps, Digital Health Opportunities, and the Case for Integrated Patient Navigation

Author:

Sharath Srinivas

Affiliation:

Independent Researcher & Health Tech Scholar

Luton, United Kingdom

Date:

July 2026

Version:

1.0

Word Count:

~2,800 words

ABSTRACT

The United Kingdom’s National Health Service (NHS) faces a paradox: unprecedented investment in digital health infrastructure coexists with persistent patient navigation failures. Despite a £14.3 billion digital health market and 39.9 million registered NHS App users [7], approximately 7.28 million patients remain on elective treatment waiting lists, with over 105,000 waiting more than a year [1]. This white paper argues that the fundamental problem is not clinical capacity alone, but systemic fragmentation in the patient journey — a gap that existing digital health solutions, built as point solutions for single phases of care, fail to address. Drawing on peer-reviewed literature, NHS statistical data, and market analysis, this paper examines the structural causes of patient journey fragmentation, evaluates the current state of digital health connectivity in the UK, and analyses the extent of healthcare system fragmentation. The analysis concludes that without navigation-layer innovation, the UK’s digital health transformation risks digitising dysfunction rather than resolving it.

---

**Keywords: **healthcare navigation, patient journey, digital health, NHS waiting lists, health system fragmentation, integrated care, UK digital health policy

1. INTRODUCTION

In March 2026, the NHS elective waiting list in England stood at 7.28 million cases, representing approximately 6.16 million individual patients waiting for treatment [1]. Of these, roughly 2.51 million had been waiting over 18 weeks — the NHS constitutional standard — and approximately 105,000 had been waiting more than a year [2]. The median waiting time for patients waiting to start treatment was 12.4 weeks, a significant increase from the pre-COVID median of 7.7 weeks in April 2019 [3].

These figures are not merely statistics. They represent millions of individuals navigating an increasingly complex healthcare system without adequate guidance — uncertain which specialist to consult, unclear about referral pathways, confused by medical reports, and struggling to maintain adherence to treatment plans. The COVID-19 pandemic exposed and amplified these fractures, but they existed long before [4].

This white paper examines a critical but underexplored dimension of the UK’s healthcare crisis: the fragmentation of the patient journey. It argues that while the UK has invested heavily in digital health infrastructure — telehealth, electronic health records, patient portals, and AI diagnostic tools — these investments have largely failed to address the navigational gaps that prevent patients from moving efficiently through the healthcare system. The result is a paradox: more digital health tools than ever, yet patients more lost than ever.

The author’s interest in this problem stems from both personal and professional experience. Surrounded by family members in medical professions — pharmacists, doctors, and diagnostic centre operators — and having lost a grandmother to COVID-19 complications exacerbated by delayed care navigation, the urgency of this gap became deeply personal. Combined with a multidisciplinary engineering background and a Master’s degree in Renewable Energy and Sustainable Technology, the author approaches healthcare navigation as a systems design problem: one that requires integrated, sustainable solutions rather than fragmented point interventions.

2. THE FRAGMENTED PATIENT JOURNEY: A FOUR-PHASE ANALYSIS

The typical patient journey can be deconstructed into four interdependent phases. Current digital health solutions excel in isolated phases but fail to create continuity across the whole. This section examines each phase and the fragmentation that occurs at the boundaries between them.

2.1 Phase 1: Symptom Identification and Initial Triage

When patients first experience symptoms, they face immediate uncertainty: Is this serious? Do I need a GP, a specialist, or emergency care? The NHS 111 service and symptom checker apps like Ada Health provide triage guidance, but they typically stop at the point of recommendation — directing the patient to a care setting without accompanying them through what happens next. A systematic review of patient navigation programs found that while navigators expand access to screenings and health services for vulnerable patients, the evidence for improving clinical outcomes or reducing secondary care use remains insufficient, suggesting that navigation without continuity has limited impact [8].

2.2 Phase 2: Provider Discovery and Access

Once a patient decides to seek care, the next challenge is finding the right provider. In the UK’s mixed public-private system, patients must navigate between NHS GPs, private specialists, diagnostic centres, and hospitals — often with no clear comparison of waiting times, quality metrics, or referral pathways. Platforms like Doctify provide provider reviews and booking for the private sector, but lack integration with NHS referral systems or clinical context from the patient’s symptom history. The result is a disconnected search experience that does not leverage what the patient has already communicated about their condition.

2.3 Phase 3: Diagnosis Comprehension and Record Management

After consultation and testing, patients receive complex medical reports — blood work, imaging, discharge summaries — that are often incomprehensible to non-clinicians. The NHS App provides access to GP records for 39.9 million registered users [7], but record access is not the same as record understanding. Patients struggle to interpret terminology, identify abnormalities, or know which questions to ask at follow-up appointments. This information gap creates anxiety, delays second opinions, and reduces informed consent quality.

2.4 Phase 4: Treatment Adherence and Long-Term Management

The final phase — treatment and recovery — requires sustained engagement: medication adherence, appointment attendance, lifestyle modification, and chronic disease monitoring. Yet medication reminder apps, chronic care platforms, and wearable integrations operate as siloed tools. A patient using a symptom checker in Phase 1 has no connection to their medication tracker in Phase 4, and their provider has no visibility into whether the patient is following the care plan prescribed in Phase 3. This discontinuity is a primary driver of missed appointments, medication non-adherence, and poor long-term outcomes [15].

3. THE DIGITAL HEALTH PARADOX: MORE TOOLS, LESS COHERENCE

The UK digital health market was valued at approximately £14.3 billion in 2025 and is projected to reach £38.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.16% [5]. Telehealth dominates current spend, followed by electronic health records, medical apps, and healthcare analytics. Chronic disease management accounts for 41.13% of digital health expenditure, while diagnostics and decision support represent the fastest-growing segment at 21.28% CAGR [6].

Despite this investment, the patient experience remains fragmented. A 2024 analysis of digital health’s role in addressing the NHS waiting list crisis identified several promising interventions — behaviour change apps, remote monitoring, digitised clinical workflows, AI-assisted prioritisation, and predictive analytics — but noted that these tools remain largely disconnected from one another [17]. The author of that analysis concluded that ‘embracing this digital healthcare strategy is not merely a response to a crisis; it is a strategic step towards a future-ready NHS ecosystem,’ yet the ecosystem remains stubbornly unintegrated.

The structural problem is that most health systems operate a primary electronic health record (EHR) alongside 15 to 30 outdated departmental applications — for labs, imaging, pharmacy, billing, HR, and facilities [18]. None of these are designed to create a seamless experience for patients. Organisations making progress have shifted focus from replacing these systems to building an ‘experience layer’ on top of them — but this layer remains largely absent in the UK patient-facing digital health landscape.

4. HOW WELL IS THE NHS CONNECTED? ASSESSING DIGITAL HEALTH CONNECTIVITY

The NHS has made significant strides in digital infrastructure. The NHS App, with 39.9 million registered users and 62.3 million annual repeat prescription orders, demonstrates that patients will adopt digital health tools at scale [7]. GP records are increasingly digitised, and the NHS Long Term Plan explicitly commits to a digital-first approach to healthcare delivery.

However, connectivity does not equal integration. The NHS App is broad and free but not AI-personalised or cross-provider. It provides transactional services — appointment booking, prescription ordering, record viewing — but does not guide patients through the care journey. A patient can view their blood test results but receives no explanation of what those results mean. They can book a GP appointment but receive no guidance on whether a specialist referral might be more appropriate. They can order a repeat prescription but receive no adherence coaching or interaction warnings.

The NHS’s internal connectivity is equally fragmented. Most NHS trusts operate a primary EHR alongside 15 to 30 departmental applications that do not communicate with one another [18]. Laboratory systems, imaging systems, pharmacy systems, and GP practice management systems often exist as separate data silos. The result is that a patient’s complete health record is distributed across multiple systems, none of which provide a unified view of the patient’s journey.

Interoperability standards such as FHIR (Fast Healthcare Interoperability Resources) offer a technical pathway to integration, but adoption remains uneven. The NHS’s own Digital Technology Assessment Criteria (DTAC) requires interoperability as a precondition for procurement, yet the patient-facing layer of the NHS digital ecosystem remains transactional rather than navigational [23].

5. HOW VAST IS THE FRAGMENTATION? QUANTIFYING THE GAPS

The scale of healthcare fragmentation in the UK can be quantified across multiple dimensions:

· Waiting list fragmentation: 7.28 million cases on elective waiting lists [1], with median waits of 12.4 weeks [3] and over 105,000 patients waiting more than a year [2]. These patients exist in a navigation void — registered but not guided.

· A&E fragmentation: 36.2% of A&E attendees wait over four hours [3], many of whom arrived because they could not navigate primary care or urgent care alternatives effectively.

· Digital tool fragmentation: The UK digital health market comprises hundreds of point solutions — symptom checkers, booking platforms, record viewers, medication reminders — with no dominant integrated platform [5, 6].

· Data fragmentation: Patient health data is distributed across GP systems, hospital EHRs, laboratory information systems, imaging archives, and pharmacy databases, with limited patient-facing integration [18].

· Provider fragmentation: Patients must navigate between NHS GPs, NHS specialists, private GPs, private hospitals, diagnostic centres, and pharmacies — each with separate booking systems, records, and referral pathways.

A systematic review of system navigation programs examined 21 intervention studies and found that while navigators expand access to screenings and health services, the evidence for improving clinical outcomes or reducing secondary care use remains insufficient [8]. This suggests that even when navigation is provided, it is often too narrow in scope — focused on a single transition point rather than the entire journey — to produce measurable system-level improvements.

The evidence scan of health system navigation research published between 2017 and 2023 identified consistent themes: navigation must include community and social dimensions; implementation requires clear operational processes, adequate resources, and strong inter-organisational partnerships; and navigator roles must be clearly defined with appropriate training and supervision [12]. These findings suggest that the fragmentation problem is not merely technical but organisational — requiring systemic coordination that current digital infrastructure does not provide.

6. EVIDENCE FROM SYSTEMATIC REVIEWS: WHAT WORKS IN NAVIGATION

A comprehensive systematic review of system navigation programs linking primary care with community-based health and social services examined 21 intervention studies with generally low to moderate risk of bias [8]. The review identified four navigation models: lay person-led (48%), health professional-led (19%), team-based (29%), and self-navigation with lay support (5%). The findings were instructive:

· Team-based system navigation may result in slightly more appropriate health service utilisation compared to baseline or usual care (evidence from three low-risk-of-bias studies) [8].

· Lay person-led and health professional-led models may improve patient experiences with quality of care compared to usual care (evidence from four moderate-risk-of-bias studies) [8].

· It remains unclear whether any navigation model consistently improves patient-related outcomes such as health-related quality of life, health behaviours, or wellbeing [8].

· Evidence is very uncertain about effects on caregiver outcomes, cost-related outcomes, or social care outcomes [8].

These findings suggest that navigation programs show promise but are hampered by heterogeneity in design, implementation, and measurement. The review authors concluded that ‘further research is needed to determine the effects on caregiver and cost-related outcomes’ [8] — a gap that reflects the broader fragmentation of both research and practice in this domain.

A separate evidence scan identified that successful navigation requires clear operational processes, adequate resources, and strong inter-organisational partnerships [12]. Yet the UK health system — with its split between NHS and private providers, its multiple commissioning bodies, and its legacy IT infrastructure — is structurally ill-equipped to deliver this coordination at scale.

7. REGULATORY AND POLICY CONSIDERATIONS

The UK’s regulatory framework for digital health is evolving. Under the UK Medical Devices Regulations 2002 (as amended), software with a medical purpose — including diagnosis, prevention, monitoring, or treatment — qualifies as a medical device. The Medicines and Healthcare products Regulatory Agency (MHRA) is aligning its software risk categorisation with the international IMDRF framework, with Class I (self-certified) for low-risk navigation tools and Class IIa+ (Approved Body assessment) for diagnostic or predictive AI [20].

For navigation platforms that provide care-pathway suggestions without diagnostic conclusions, Class I self-certification with UKCA marking and MHRA registration is the likely pathway. However, any feature involving disease progression forecasting, predictive risk scoring, or diagnostic-adjacent AI would trigger Class IIa or higher classification, requiring ISO 13485 quality management systems and clinical validation evidence [20]. Platform architects must design with this boundary in mind from inception.

Data protection is equally critical. Health data is ‘special category data’ under UK GDPR Article 9 [21], requiring a Data Protection Impact Assessment (DPIA) before launch, lawful basis for processing, and compliance with the NHS Data Security and Protection Toolkit (DSPT) [22] before any NHS-facing engagement. The NHS’s Digital Technology Assessment Criteria (DTAC) provides a pre-procurement checklist that navigation platforms must satisfy before NHS pilot contracts [23].

8. IMPLICATIONS FOR POLICYMAKERS, INVESTORS, AND INNOVATORS

For NHS policymakers, the implication is clear: digital health procurement must prioritise journey integration over feature accumulation. The NHS App’s 39.9 million registered users demonstrate that patients will adopt digital health tools at scale [7] — but adoption is not the same as navigation. Future procurement should require interoperability standards (FHIR-based APIs), outcome measurement, and patient journey continuity as core evaluation criteria.

For investors, the healthcare navigation platform market represents a serviceable addressable market (SAM) in the mid-hundreds of millions of dollars in the UK alone, growing at double-digit rates annually [5, 6]. The global market for healthcare navigation platforms is projected to reach $22–26 billion by 2030–2035 [5]. However, the investment thesis must rest on integration moats — longitudinal data, cross-provider network effects, and regulatory trust — rather than single-feature novelty.

For innovators, the lesson from failed predecessors — most notably Babylon Health, which collapsed in 2023 after over-promising clinical accuracy while under-delivering on trust and unit economics — is that boundary discipline matters [17]. Any platform entering this space must be architecturally incapable of making diagnostic claims, with that limitation evidenced in design rather than only in marketing.

9. CONCLUSION

The UK’s healthcare system does not lack digital health tools. It lacks digital health coherence. With 7.28 million patients on waiting lists [1], 36.2% of A&E attendees waiting over four hours [3], and a digital health market growing at 11% annually [5], the gap between investment and outcome is not a capacity problem alone — it is a navigation problem.

This white paper has examined the structural causes of patient journey fragmentation across four critical phases — symptom identification, provider discovery, diagnosis comprehension, and treatment adherence — and has demonstrated that existing digital health solutions, while strong in isolation, fail to bridge these phases into a continuous, coherent experience. The NHS is digitally connected in parts but not integrated as a system. The fragmentation is vast, quantifiable, and growing.

Systematic review evidence confirms that navigation programs can improve access and patient experience, but only when implemented with clear operational processes, adequate resources, and strong inter-organisational partnerships [8, 12] — conditions that the current UK health system structure does not readily provide. The path forward requires a fundamental shift: not more point solutions for single problems, but an integrated operating layer that orchestrates the patient’s entire healthcare journey. Without it, the UK risks digitising dysfunction rather than resolving it. With it, the UK has the opportunity to build a healthcare system that is not only universally available, but universally navigable.

---

ABOUT THE AUTHOR

Sharath Srinivas is a health tech scholar and independent researcher based in Luton, United Kingdom. With an MSc in Renewable Energy and Sustainable Technology from the University of South Wales and a multidisciplinary engineering background, he applies systems-thinking principles to healthcare navigation challenges. His research focuses on patient journey fragmentation, AI-assisted care coordination, and the regulatory frameworks governing digital health innovation in the UK. He is currently engaged in full-time research and analysis to identify sustainable pathways for improving healthcare delivery and patient outcomes. For inquiries: sharathsrinivas0219@gmail.com

---

This white paper was researched and written by Sharath Srinivas, a health tech scholar and independent researcher based in Luton, United Kingdom. For inquiries, contact: sharathsrinivas0219@gmail.com

---

REFERENCES

[1] NHS England. Consultant-Led Referral to Treatment (RTT) Waiting Times. Monthly statistical releases, March–May 2026. Available at: https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/

[2] British Medical Association (BMA). NHS Backlog Data Analysis. June 2026. Available at: https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/nhs-backlog-data-analysis

[3] House of Commons Library. NHS Key Statistics: England. May 2026. CBPP-7281. Available at: https://commonslibrary.parliament.uk/research-briefings/cbp-7281/

[4] Institute for Fiscal Studies (IFS). The Past and Future of NHS Waiting Lists in England. February 2024. Available at: https://ifs.org.uk/publications/past-and-future-nhs-waiting-lists-england

[5] IMARC Group. UK Digital Health Market Size, Statistics & Forecast 2034. 2026. Available at: https://www.imarcgroup.com/uk-digital-health-market

[6] Mordor Intelligence. United Kingdom Digital Health Market. February 2026.

[7] NHS England. NHS App Management Information Statistics. November 2025 — April 2026.

[8] Teggart, S. et al. Effectiveness of system navigation programs linking primary care with community-based health and social services: a systematic review. BMC Health Services Research, 2023. 23: 594. doi: 10.1186/s12913–023–09424–5

[9] Valaitis, R. et al. Implementation and maintenance of patient navigation programs linking primary care with community-based health and social services: a scoping literature review. BMC Health Services Research, 2017. 17: 116. doi: 10.1186/s12913–017–2046–1

[10] Carter, N. et al. Navigation delivery models and roles of navigators in primary care: a scoping literature review. BMC Health Services Research, 2018. 18: 96. doi: 10.1186/s12913–018–2889–0

[11] Budde, H. et al. The role of patient navigators in ambulatory care: overview of systematic reviews. BMC Health Services Research, 2021. 21: 1176. doi: 10.1186/s12913–021–07170–1

[12] Newfoundland & Labrador Centre for Applied Health Research. Health System Navigation: Evidence Scan. December 2023. Available at: https://www.mun.ca/nlcahr

[13] Freeman, H.P. & Rodriguez, R.L. History and principles of patient navigation. Cancer, 2011. 117(S15): 3537–3540. doi: 10.1002/cncr.26262

[14] Tang, K.L. & Ghali, W.A. Patient navigation — exploring the undefined. JAMA Health Forum, 2021. 2(11): e213706. doi: 10.1001/jamahealthforum.2021.3706

[15] McBrien, K.A. et al. Patient navigators for people with chronic disease: a systematic review. PLoS ONE, 2018. 13(2): e0191980. doi: 10.1371/journal.pone.0191980

[16] Chan, R.J. et al. Patient navigation across the cancer care continuum: an overview of systematic reviews and emerging literature. CA: A Cancer Journal for Clinicians, 2023. 73(6): 565–589. doi: 10.3322/caac.21788

[17] MedHealth Outlook. The NHS Waiting List Crisis and How Digital Health Can Help Solve It. January 2024. Available at: https://medhealthoutlook.com

[18] Liferay. Digital Transformation in Healthcare: Priorities, Challenges, and What’s Actually Working in 2026. March 2026.

[19] Health Data Research UK (HDR UK). Waiting List Conference 2026: From Backlog to Breakthrough. July 2026. Available at: https://www.hdruk.ac.uk/events/waiting-list-conference-2026-from-backlog-to-breakthrough/

[20] MHRA. Software and AI as a Medical Device: Guidance. 2026. Available at: https://www.gov.uk/government/collections/software-and-artificial-intelligence-ai-as-a-medical-device

[21] UK GDPR. Data Protection Act 2018. Special Category Data (Article 9). Available at: https://www.legislation.gov.uk/ukpga/2018/12

[22] NHS Digital. Data Security and Protection Toolkit (DSPT). Available at: https://digital.nhs.uk/cyber-security/data-security-and-protection-toolkit

[23] NHS Digital. Digital Technology Assessment Criteria (DTAC). Available at: https://digital.nhs.uk/services/digital-technology-assessment-criteria-dtac